Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma
- Status
- TERMINATED
- Phase
- PHASE2
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects
- Status
- TERMINATED
- Phase
- PHASE3
Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Systemic Corticosteroids Avoidance Study in Severe Asthma Patients
- Status
- TERMINATED
- Phase
- PHASE3
Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE3
Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Managed Access Programs for CTL019, Tisagenlecleucel
- Status
- AVAILABLE
- Phase
- N/A
Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.
- Status
- WITHDRAWN
- Phase
- PHASE3
A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2